4basebio
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
25 Norman Way, Over, Cambridgeshire, CB2...Phone Number
+44 1223967943Website
www.4basebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About 4basebio
4basebio specializes in the design and manufacture of GMP-grade synthetic DNA and non-viral nanoparticles for efficient gene delivery. Their proprietary technologies are customizable and offer advantages over traditional plasmid DNA and non-targeted lipid nanoparticles. The company caters to applications in gene therapy, DNA vaccines, gene editing, and targeted delivery systems. Intended clients include pharmaceutical and biotechnology companies seeking advanced gene synthesis and delivery solutions.Explore more
4basebio Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is 4basebio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if 4basebio had a recent Job posting/layoffs
Product Launch: Get notified when 4basebio launches new products
Earning: See what the market has to say on 4basebio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if 4basebio is spiking on competitors!
Funding: Get notified immidiatlly once 4basebio has new funding data
Check if 4basebio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at 4basebio
Website visits: Recent activity has been detected on your website
4basebio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined 4basebio as Masked Content
Find 2 more new buyers
Compare Similar Companies to 4basebio
Compare insights from companies similar to 4basebio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
4basebio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
4basebio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about 4basebio.
4basebio financials insights
Gather financial insights about 4basebio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$1.6M
4basebio Tech Stack
A closer look at the technologies used by 4basebio
Most Recent Scoops
Event
Product Marketing, Events, Sales, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Research & Development, Bioengineering, Manufacturing Operations
New Hire
Executive Move
Executive Moves, New Hire
4basebio News & Media
4basebio PLC Promotes Christine Wolosin to Chief Commercial Officer - MarketScreener
4basebio PLC announced the promotion of Christine Wolosin to Chief Commercial Officer. Christine, who joined 4basebio in September 2025 as Vice President, Business Development, will lead the Company's...4basebio : appoints Amy Walker, PhD as Chief Executive Officer | MarketScreener
4basebio appoints Amy Walker, PhD as Chief Executive Officer 10 Feb Written By Jennifer Gelman4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies
CAMBRIDGE, England--(BUSINESS WIRE)--4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. Since completing its £40 million investment in November 2024, 4basebio has achieved several major milestones in its mission to deliver scalable, high-quality synthetic DNA
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding 4basebio
Sign Up For FreeTo access detailed company insights
4basebio specializes in the design and manufacture of GMP-grade synthetic DNA and non-viral nanoparticles for efficient gene delivery. Their proprietary technologies are customizable and offer advantages over traditional plasmid DNA and non-targeted lipid nanoparticles. The company caters to applications in gene therapy, DNA vaccines, gene editing,... Read More
